Literature DB >> 19482243

Lapatinib for inflammatory breast cancer.

Peter S Hall, Andrew Hanby, David A Cameron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19482243     DOI： 10.1016/S1470-2045(09)70120-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.

Authors:  Liang-Hui Chu; Brian H Annex; Aleksander S Popel
Journal:  Front Pharmacol       Date:  2015-08-25       Impact factor: 5.810

2.  Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response.

Authors:  Roberto Martin Huertas; María Fernández Abad; Elena Corral de la Fuente; Juan José Serrano Domingo; Noelia Martínez Jáñez
Journal:  Breast J       Date:  2019-09-29       Impact factor: 2.431
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.